The laboratory diagnosis of Trichomonas vaginalis

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 16, Issue 1, 2005, Pages 35-38

  Garber, Gary E ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Diagnostic tests; STI; Trichomonas vaginalis; Vaginitis

Indexed keywords

METRONIDAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIBODY DETECTION; CLINICAL FEATURE; COMPLEMENT FIXATION TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION TEST; HUMAN; INCIDENCE; LABORATORY DIAGNOSIS; MICROSCOPY; NUCLEIC ACID ANALYSIS; PARASITE CULTIVATION; PARASITE IDENTIFICATION; POLYMERASE CHAIN REACTION; QUALITY CONTROL; REVIEW; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

EID: 16344390257     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/373920     Document Type: Review

References (27)

1. World Health Organization. An overview of selected curable sexually transmitted diseases. In: Global program on AIDS. World Health Organization, Switzerland, 1995:2-27.
2. Hardy PH, Hardy JB, Nell EE, Graham DA, Spence MR, Rosenbaum RC. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 1984;2:333-7.
3. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: A prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984;150:965-72.
4. Gram IT, Macaluso M, Churchill J, Stalsberg H. Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control 1992;3:231-6.
5. Krieger JN. Trichomoniasis in men: Old issues and new data. Sex Transm Dis 1995;22:83-96.
6. Krieger JN. Prostatitis syndromes: Pathophysiology, differential diagnosis, and treatment. Sex Transm Dis 1984;11:100-12.
7. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993;7:95-102.
8. Laga M, Nzila N, Goeman J. The interrelationship of sexually transmitted diseases and HIV infection: Implications for the control of both epidemics in Africa. AIDS 1991;5(Suppl 1):S55-63.
9. Cotch MF, et al. Effects of Trichomonas vaginalis carriage on pregnancy outcome. International Society for STD Research. Banff Alta, October 1991 (Abst).
10. Cotch MF, Pastorek JG 2nd, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997;24:353-60.
11. Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998;11:300-17.
12. Donné A. Animacules observés dans les matières purulentes et le produit des secretions des organes genitaux de l'homme et de la femme. CR Acad Sci 1836;3:385-6.
13. Garber GE, Sibau L, Ma R, Proctor EM, Shaw CE, Bowie WR. Cell culture compared with broth for detection of Trichomonas vaginalis. J Clin Microbiol 1987;25:1275-9.
14. Beal C, Goldsmith R, Kotby M, et al. The plastic envelope method, a simplified technique for culture diagnosis of trichomoniasis. J Clin Microbiol 1992;30:2265-8.
15. Levett PN. A comparison of five methods for the detection of Trichomonas vaginalis in clinical specimens. Med Lab Sci 1980;37:85-8.
16. Perl G. Errors in the diagnosis of Trichomonas vaginalis infections as observed among 1199 patients. Obstet Gynecol 1972;39:7-9.
17. Riley DE, Roberts MC, Takayama T, Krieger JN. Development of a polymerase chain reaction-based diagnosis of Trichomonas vaginalis. J Clin Microbiol 1992;30:465-72.
18. Briselden AM, Hillier SL. Evaluation of affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. J Clin Microbiol 1994;32:148-52.
19. Crucitti T, Van Dyck E, Tehe A, et al. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect 2003;79:393-8.
20. Shafer MA, Moncada J, Boyer CB, Betsinger K, Flinn SD, Schachter J. Comparing first void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid test. J Clin Microbiol 2003;41:4395-9.
21. Rubino S, Muresu R, Rappelli P, et al. Molecular probe for identification of Trichomonas vaginalis DNA. J Clin Microbiol 1991;29:702-6.
22. Kaydos-Daniels SC, Miller WC, Hoffman I, et al. Validation of a urine-based PCR-ELISA for use in clinical research settings to detect Trichomonas vaginalis in men. J Clin Microbiol 2003;41:318-23.
23. Garber GE, Proctor EM, Bowie WR. Immunogenic proteins of Trichomonas vaginalis as demonstrated by the immunoblot technique. Infect Immun 1986;51:250-3.
24. Krieger JN, Holmes KK, Spence MR, Rein MF, McCormack WM, Tam MR. Geographic variation among isolates of Trichomonas vaginalis: Demonstration of antigenic heterogeneity by using monoclonal antibodies and the indirect immunofluorescence technique. J Infect Dis 1985;152:979-84.
25. Lossick JG, Kent HL. Trichomoniasis: Trends in diagnosis and management. Am J Obstet Gynecol 1991;165:1217-22.
26. Muller M, Lossick JG, Gorrell TE. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex Transm Dis 1988;15:17-24.
27. Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev 2004;17:783-93.